Hospital Txagorritxu
Vitoria, Spain
University hospital in Vitoria-Gasteiz
Jose Atxotegi Kalea, s/n, 01009 Gasteiz, Araba
About Hospital Txagorritxu
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
PETHEMA Foundation
17
Basque Health Service
5
Celgene
2
Eli Lilly and Company
2
Fresenius Medical Care Deutschland GmbH
2
Spanish Breast Cancer Research Group
2
Terumo Europe N.V.
2
University of Minnesota
2
Asociación Cacereña para la Investigación y el Desarrollo en Oncología Médica
1
EMD Serono Research & Development Institute, Inc.
1
Forest Laboratories
1
Clinical Trials at Hospital Txagorritxu
During the past decade, Hospital Txagorritxu conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 7 clinical trials were completed, i.e. on
average, 36.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer
1999-03-01
2007-04-01
Completed
Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation.
2001-02-01
2003-06-01
Completed
658
FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients
2003-09-19
2013-10-01
Completed
1,925
Trial to Compare the Safety,Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus Vaccine, Trivalent, Inactivated (TIV) in Children
2002-10-01
2003-06-01
Completed
2,200
Rituximab Combined With Chemotherapy in Burkitt's Lymphoma
2006-08-01
2013-12-01
Completed
20
Treatment of Acute Myeloblastic Leukemia in Younger Patients
1999-01-01
2010-01-01
Completed
600
Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)
2005-07-01
2013-12-01
Completed
300
GEM05 for Patients With Multiple Myeloma More Than 65 Years Old
2005-03-01
2009-12-01
Completed
260
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital Txagorritxu" #1 sponsor was "PETHEMA Foundation" with 17 trials, followed by "Basque Health Service" with 5 trials
sponsored, "Celgene" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Fresenius Medical Care Deutschland GmbH"
with 2 trials sponsored. Other sponsors include 22 different institutions and
companies that sponsored additional 29 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Txagorritxu"
#1 collaborator was "Bristol-Myers Squibb" with 3 trials as a collaborator, "Celgene" with 2 trials as a collaborator, "Dynamic Science S.L." with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator and "National Institutes of Health (NIH)" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were
collaborators in the rest 26 trials.
Clinical Trials Conditions at Hospital Txagorritxu
According to Clinical.Site data, the most researched conditions in "Hospital Txagorritxu" are
"Multiple Myeloma" (7 trials), "Chronic Hepatitis C" (3 trials), "Acute Lymphoblastic Leukemia" (2 trials), "Acute Promyelocytic Leukemia" (2 trials) and "Chronic Obstructive Pulmonary Disease" (2 trials). Many other conditions were trialed in "Hospital Txagorritxu" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Txagorritxu
Most popular intervention types in "Hospital Txagorritxu" are "Drug" (33 trials), "Other" (7 trials), "Procedure" (4 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Dexamethasone" (4 trials), "Placebo" (4 trials), "Melphalan" (3 trials), "Prednisone" (3 trials) and "ATRA" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Txagorritxu
The vast majority of trials in "Hospital Txagorritxu" are
49 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Hospital Txagorritxu
Currently, there are NaN active trials in "Hospital Txagorritxu".
1 are not yet recruiting,
4 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 39 completed trials in Hospital Txagorritxu,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Txagorritxu, 0 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 17 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 9 trials, and there were
also 7 trials that are defined as “Not Applicable".